1. Home
  2. RVMD vs BEPC Comparison

RVMD vs BEPC Comparison

Compare RVMD & BEPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • BEPC
  • Stock Information
  • Founded
  • RVMD 2014
  • BEPC 2019
  • Country
  • RVMD United States
  • BEPC United States
  • Employees
  • RVMD N/A
  • BEPC N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • BEPC Electric Utilities: Central
  • Sector
  • RVMD Health Care
  • BEPC Utilities
  • Exchange
  • RVMD Nasdaq
  • BEPC Nasdaq
  • Market Cap
  • RVMD 7.5B
  • BEPC 6.1B
  • IPO Year
  • RVMD 2020
  • BEPC N/A
  • Fundamental
  • Price
  • RVMD $37.81
  • BEPC $35.31
  • Analyst Decision
  • RVMD Strong Buy
  • BEPC Buy
  • Analyst Count
  • RVMD 13
  • BEPC 3
  • Target Price
  • RVMD $68.38
  • BEPC $31.67
  • AVG Volume (30 Days)
  • RVMD 3.3M
  • BEPC 960.1K
  • Earning Date
  • RVMD 08-06-2025
  • BEPC 08-01-2025
  • Dividend Yield
  • RVMD N/A
  • BEPC 4.23%
  • EPS Growth
  • RVMD N/A
  • BEPC N/A
  • EPS
  • RVMD N/A
  • BEPC N/A
  • Revenue
  • RVMD N/A
  • BEPC $3,923,000,000.00
  • Revenue This Year
  • RVMD N/A
  • BEPC $44.37
  • Revenue Next Year
  • RVMD $226.82
  • BEPC $7.44
  • P/E Ratio
  • RVMD N/A
  • BEPC N/A
  • Revenue Growth
  • RVMD N/A
  • BEPC N/A
  • 52 Week Low
  • RVMD $29.17
  • BEPC $23.73
  • 52 Week High
  • RVMD $62.40
  • BEPC $35.54
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 46.33
  • BEPC 69.65
  • Support Level
  • RVMD $36.37
  • BEPC $32.65
  • Resistance Level
  • RVMD $38.97
  • BEPC $34.28
  • Average True Range (ATR)
  • RVMD 1.34
  • BEPC 0.84
  • MACD
  • RVMD 0.07
  • BEPC 0.02
  • Stochastic Oscillator
  • RVMD 37.26
  • BEPC 92.91

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

About BEPC Brookfield Renewable Corporation

Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia, and totals over 40 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners LP and Brookfield Renewable Corp.

Share on Social Networks: